said Friday that it is exploring a potential company sale.
The health care services company hired UBS Securities as a financial adviser to help it explore strategic alternatives. The company said the alternatives may include a full or partial sale of the company, a merger or no moves at all.
Horizon's shares were battered in July after the company missed Wall Street's third-quarter earnings estimates and slashed its full-year forecast, citing pricing pressures on its behavioral health-management contract business.
The stock recently was down 10 cents to $16.64.